Provided by Tiger Trade Technology Pte. Ltd.

Tradr 2X Long TEM Daily ETF

34.31
-5.1100-12.96%
Post-market: 34.17-0.1400-0.41%19:59 EDT
Volume:273.91K
Turnover:9.80M
Market Cap:42.49M
PE:- -
High:39.76
Open:39.48
Low:33.75
Close:39.42
52wk High:152.22
52wk Low:11.52
Shares:1.24M
Float Shares:1.24M
Volume Ratio:1.30
T/O Rate:22.12%
Dividend:3.85
Dividend Rate:11.22%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Tempus AI Inc Q2 Income from Operations USD -75.913 Million

THOMSON REUTERS
·
Jul 31

Tempus AI Inc Q2 Adjusted EPS USD -0.04 VS. Ibes Estimate USD -0.14

THOMSON REUTERS
·
Jul 31

tempus AI Inc Class A options imply 6.9% move in share price post-earnings

TIPRANKS
·
Jul 31

Median Technologies Partners with Canon’s Olea Medical to Commercialize Eyonis LCS Lung Cancer Screening Software

Reuters
·
Jul 30

Sløk Flags Systemic Cross-Asset Risks; AI Turmoil Is Just The Starting Point

Analyst Calls
·
Jul 30

More Cracks Appear Inside The AI Bond Market!

AI Industry Frontlines
·
Jul 28

Anthropic Considers Mandatory Stock Trading Plan For All Employees Ahead Of IPO, Breaking Industry Norms

Hong Kong & US IPO Tracker
·
Jul 27

AI Sector Under Massive Valuation Reset: Market Abandons Blind Capex Hype, Focuses On Cash Flow & ROI

Bellwether Stocks Movement
·
Jul 27

SAP CFO: Generic Chatbots Bring Little Profit; Enterprise Process AI Is True Growth Driver

Analyst Calls
·
Jul 24

Tempus AI announces national launch of OneOme pharmacogenomics testing

TIPRANKS
·
Jul 22

Analysts Offer Insights on Healthcare Companies: Tempus AI, Inc. Class A (TEM), Immunome (IMNM) and Incyte (INCY)

TIPRANKS
·
Jul 22

Analysts Are Neutral on These Healthcare Stocks: Cencora (COR), Avita Medical (RCEL)

TIPRANKS
·
Jul 22

Tempus AI (TEM) Stock May Trade Below Fair Value Despite Mixed Checks

Simply Wall St.
·
Jul 22

Tempus AI: Buy Rating Reaffirmed as Personalis Deal Strengthens MRD Position; $75 Price Target Maintained

TIPRANKS
·
Jul 22

Tempus AI Makes Billion-Dollar Bet on the Future of Cancer Monitoring

Benzinga_recent_news
·
Jul 22

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Tempus AI, Inc. Class A (TEM) and 4D Molecular Therapeutics (FDMT)

TIPRANKS
·
Jul 21

AI Bull Run Hits A Crossroads! Wall Street Erupts In Rare Bull-Bear Showdown

AI Industry Frontlines
·
Jul 21

Personalis Acquisition Price Warranted by Growth Prospects, Needham Says

MT Newswires Live
·
Jul 21

Morgan Stanley sees strategic logic in Personalis deal despite financial hurdles

TIPRANKS
·
Jul 21

AI Daily: Tempus AI to acquire Personalis at enterprise value of $1.5B

TIPRANKS
·
Jul 21